Factors associated with hepatitis B mother-to-child transmission in a national prevention program.

Clin Mol Hepatol

Division of Pediatric Infectious Diseases, Department of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background & Aims: Hepatitis B virus (HBV) mother-to-child transmission (MTCT) remains a global health concern, with over 90% of perinatal infections leading to chronic HBV. To evaluate long-term trends in MTCT rates and associated factors within Korea's national program.

Methods: Population-based cohort study using linked data from the Perinatal Hepatitis B Prevention Program (PHBPP) and National Health Insurance Services in Korea. The study included HBsAg-positive mother-infant pairs with post-vaccination serologic results from 2002 to 2021.

Results: Among the 154,478 mother-infant pairs, the overall MTCT rate after prophylaxis was 2.3%. Antiviral use lowered MTCT rates (0.9% vs 2.4%) particularly in HBeAg-positivity (1.0% vs 5.9%; aOR, 0.21; 95% CI, 0.14-0.32). Lower MTCT rates were observed for cesarean-section vs vaginal delivery (1.9% vs 2.6%; aOR, 0.78; 95% CI, 0.73-0.84) and breastfeeding vs formula feeding (1.8% vs 2.8%; aOR, 0.65; 95% CI, 0.56-0.76). Annual MTCT rates decreased from 3.6% (2002-2005) to 1.3% (2018-2021). Antivirals reduced MTCT rates; initiation at 14-27 weeks (0.39%), or 28-32 weeks (0.44%) vs ≥33 weeks (1.47%); postpartum continuation (0.55%) vs antepartum discontinuation (1.44%); use ≥61 days (0.51%) vs 1-60 days (1.67%). Lower MTCT risk was associated with maternal (old age, high income) and infant (female sex, pre-term birth) factors.

Conclusions: This comprehensive analysis of the PHBPP in Korea demonstrates that the use of antivirals, breastfeeding, and cesarean section, combined with conventional immunoprophylaxis, has significantly reduced MTCT rates. These results are crucial for global HBV elimination and can help to guide HBV MTCT prevention strategies.

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2025.0214DOI Listing

Publication Analysis

Top Keywords

mtct rates
24
mtct
10
mother-to-child transmission
8
prevention program
8
mother-infant pairs
8
lower mtct
8
reduced mtct
8
rates
6
factors associated
4
associated hepatitis
4

Similar Publications

To evaluate progress toward MTCT elimination of HBV, we analyzed 8-y trends in hepatitis B vaccine (HepB) and hepatitis B immune globulin (HBIG) administration coverage rates in Shandong province, focusing on high-risk populations. Data were collected from a provincial system, Shandong Vaccination Information System. Information of maternal HBsAg+ neonates born in 2017-2024 were extracted.

View Article and Find Full Text PDF

Background: To investigate the impact of tenofovir disoproxil fumarate (TDF) withdrawal timing on elevated postpartum alanine aminotransferase (ALT) levels and breastfeeding in pregnant women who received TDF therapy to prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV) infection.

Methods: All enrolled women began treatment with TDF during weeks 24-32 of pregnancy and were divided into three groups that stopped TDF at delivery (Group A), at 4 weeks postpartum (Group B), or at 12 weeks postpartum (Group C). The biochemical and virological markers of hepatitis B were regularly measured and compared.

View Article and Find Full Text PDF

Globally, mother-to-child transmission (MTCT) of HIV significantly contributes to paediatric HIV infections. Effective prevention of mother-to-child transmission (PMTCT) programs aim to achieve the World Health Organization's target of less than 5% transmission rates. This study evaluated the implementation of PMTCT services in Mwanza district, Malawi, focusing on antiretroviral therapy (ART) adherence and key implementation challenges.

View Article and Find Full Text PDF

Background And Aims: Mother-to-child transmission (MTCT) of HIV remains a significant global health challenge, particularly in resource-limited settings. The virus disrupts maternal-fetal immunity through immune dysregulation, placental barrier impairment, and altered antibody transfer, thereby increasing the risk of vertical transmission.

Methods And Results: This narrative review synthesizes current evidence on the immunological and clinical factors influencing MTCT.

View Article and Find Full Text PDF

Introduction: () primary infection during pregnancy can lead to severe consequences in the fetus and newborn, including miscarriage, congenital disease, or neuro-ophthalmological complications.

Objectives: This study aimed to evaluate the incidence of congenital toxoplasmosis (CT) in a cohort of newborns and assess their neurological, ophthalmological, and auditory sequelae. Additionally, we examined correlations between infection rates, gestational age at maternal seroconversion, prenatal treatment, and postnatal outcomes.

View Article and Find Full Text PDF